Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Aug 2007 15:38

Oxford Biomedica PLC02 August 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Man Financial Limited 4. Full name of shareholder(s) (if different from 3.) (iv): 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 1 August 2007 6. Date on which issuer notified: 2 August 2007 7. Threshold(s) that is/are crossed or reached: 3% to 2% 8. Notified details: Below 3% A: Voting rights attached to shares Class/type of shares if possible using Situation previous to the Triggering transactionthe ISIN CODE (vi) Number of shares Number of voting Rights (viii) GB0006648157 21,070,855 21,070,855 Resulting situation after the triggering transaction (vii)Class/type of shares if Number of shares Number of voting rights (ix) % of voting rightspossible using the ISINCODE Direct Direct (x) Indirect (xi) Direct Indirect GB0006648157 Below 3% Below 3% Below 3% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date ( Exercise/Conversion Number of voting rights % of voting rightsfinancial xiii) Period/Date (xiv) that may be acquired ifinstrument the instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 15,634,634 Below 3% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: None 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th May 202011:26 amRNSDirector Dealings / Market Share Purchase
22nd May 20205:28 pmRNS2019 Annual report and Accounts & AGM Notification
20th May 20202:34 pmRNSHolding(s) in Company
13th May 20206:02 pmRNSHolding(s) in Company
13th May 20207:00 amRNSOXB receives approval for first two Oxbox suites
11th May 20204:25 pmRNSPDMR Dealings / Market Share sale
6th May 202012:36 pmRNSDirectors Dealings / Market Share Purchases
6th May 20207:00 amRNSPreliminary Results
1st May 20209:05 amRNSTotal Voting Rights
28th Apr 20201:04 pmRNSCompliance with LR 9.2.6ER(1)
24th Apr 202011:48 amRNSDirector/PDMR Shareholding
23rd Apr 20208:38 amRNSHolding(s) in Company
22nd Apr 202012:03 pmRNSKymriah receives FDA RMAT designation in FL
20th Apr 20204:49 pmRNSHolding(s) in Company
16th Apr 20203:17 pmRNSNotice of Results Update
8th Apr 20207:00 amRNSOxford Biomedica joins COVID-19 vaccine Consortium
1st Apr 20209:31 amRNSTotal Voting Rights
25th Mar 20201:06 pmRNSDirector Dealings / Market Share Purchase
20th Mar 20209:56 amRNSDirector/PDMR Shareholding
18th Mar 20207:00 amRNSOxford Biomedica Business Update
18th Mar 20207:00 amRNSLicense & Supply Agreement with Juno Therapeutics
2nd Mar 20209:22 amRNSTotal Voting Rights
26th Feb 20205:55 pmRNSDirector Dealings / Market Share Purchase
3rd Feb 20205:04 pmRNSClass 2 Transaction Announcement
3rd Feb 202011:56 amRNSTotal Voting Rights
3rd Feb 202011:55 amRNSDirector Dealings / Market Share Purchase
22nd Jan 202012:11 pmRNSBlock listing Application
7th Jan 202010:17 amRNSBlock Listing Return
2nd Jan 202011:41 amRNSTotal Voting Rights
19th Dec 20193:27 pmRNSDirector Dealings / Market Share Purchase
19th Dec 20197:00 amRNSExtension of Commercial Supply Agreement
2nd Dec 20199:31 amRNSTotal Voting Rights
27th Nov 201910:05 amRNSDirector Dealings / Market Share Purchase
13th Nov 20194:41 pmRNSHolding(s) in Company
1st Nov 20199:25 amRNSTotal Voting Rights
28th Oct 201912:30 pmRNSDirector Dealings / Market Share Purchase
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
16th Oct 20197:30 amEQSHardman & Co Research: Oxford BioMedica (OXB): Demanding second half
1st Oct 201910:18 amRNSTotal Voting Rights
25th Sep 201911:41 amRNSDirector Dealings / Market Share Purchase
16th Sep 201911:18 amRNSDirector/PDMR Shareholding
16th Sep 20199:15 amRNSDirectors Dealings / Market Share Purchases
13th Sep 20192:57 pmRNSLong Term Incentive Plan Option Grant
13th Sep 20191:13 pmRNSDirectors Dealings / Market Share Purchases
13th Sep 201910:53 amRNSDirector Dealings / Market Share Purchase
4th Sep 20197:00 amRNSOxford Biomedica Interim Results
2nd Sep 20199:31 amRNSTotal Voting Rights
23rd Aug 201911:06 amRNSDirector Dealings / Market Share Purchase
9th Aug 201912:00 pmRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.